NCT03100110 - NeuroCognitive Communicator: Safety Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 13, 2019

Primary Completion Date

April 15, 2024

Study Completion Date

April 15, 2024

Conditions

Motor Neuron Disease, Amyotrophic Lateral SclerosisTetraplegia

Interventions

DEVICE

NeuroCognitive Communicator

Comprises an electrode array in prefrontal cortex, another in motor cortex, Blackrock NeuroPort system and connectors, augmentative assistive communication application, robotic arm, and virtual reality environment.

Trial Locations (1)

K1Y 4E9

RECRUITING

The Ottawa Hospital, Ottawa